Pulmonx

Update in progress

LUNG (NasdaqGS)

Pulmonx Corporation is a commercial-stage medical technology company that offers minimally invasive treatments for severe emphysema, a form of COPD. It provides the Zephyr Endobronchial Valve and the Chartis Pulmonary Assessment System to assess collateral ventilation. Its LungTraX Platform includes LungTraX Connect, LungTraX Detect, and StratX Lung for CT analysis and identifying target lobes for valve treatment. Headquartered in Redwood City, California, it serves customers worldwide.